Rapid Move Following Outpatient Surgery: Safety and Patient Characteristics

NCT06742658 | Not Yet Recruiting

• 1 other identifier: MMS.2024.079
• Study Type: observational
• Target: 1,500
• Locations: 1 country
• Sites: 1

Brief Summary

A descriptive, retrospective cohort study will be conducted to gain insight in the safety of the Rapid Move. The trial will include a group of Rapid Move patients, who were transferred to the Rapid Move after their outpatient surgery and subsequently discharged home. The Rapid Move is a short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

Conditions

Postoperative Recovery

Keywords

Postoperative recovery; PACU; Rapid Move

Outcome Measures

Primary Outcomes (1)

• 30-day readmission

  The 30-day readmission rate is defined as the number of patients with an unplanned emergency hospital readmission, including emergency department (ED) visits with or without hospital readmission, occurring between the time the patient is discharged from the hospital after their outpatient surgery (index hospital admission) and 30 days after the surgery. An admission to a non-acute care facility is not considered a readmission. A readmission must be clinically related to the index hospital admission. The term 'clinically related' is defined as meaning that the underlying reason for readmission is plausibly related to the care rendered during or immediately following a prior hospital admission. A clinically related readmission may have resulted from the process of care and treatment during the prior admission or from a lack of post-admission follow-up, rather than from events that occurred after the prior admission within a specified readmission time interval that are unrelated to the p

  Up to 30 days after hospital discharge.

Secondary Outcomes (2)

• Complications

  Up to 30 days after hospital discharge.

• Length of Stay

  Minutes, up to 4 hours.

Study Arms (1)

All patients undergoing an outpatient procedure eligible for the Rapid Move.

Patients who went to the Rapid Move after their outpatient procedure. Eligible procedures are: gastroscopy, coloscopy, vasectomy, scrotal surgery, circumcision or other minor penile surgery, intravesical Botox, insertion or removal of eardrum tubes in adults, sinus irrigation in adults, sleep endoscopy, bronchoscopy, removal of osteosynthetic material in the lower leg and foot, and tooth extraction (including wisdom teeth) and upper-forearm orthopaedic surgery (excluding prosthetic surgery).

Other: Rapid Move

Interventions

Rapid Move OTHER

A short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

All patients undergoing an outpatient procedure eligible for the Rapid Move.

Eligibility Criteria

• Age: 15 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

This study will include an intervention group with all consecutive patients, aged 15 years or older, who went to the Rapid Move after their outpatient procedure between 1 December 2023 and 1 December 2024 in general hospital Maria Middelares, Ghent, Belgium (Rapid Move patients).

You may qualify if:

• Patients aged 15 years or older;
• Patients who went to the Rapid Move after their outpatient procedure. Eligible procedures are: gastroscopy, coloscopy, vasectomy, scrotal surgery, circumcision or other minor penile surgery, intravesical Botox, insertion or removal of eardrum tubes in adults, sinus irrigation in adults, sleep endoscopy, bronchoscopy, removal of osteosynthetic material in the lower leg and foot, and tooth extraction (including wisdom teeth) and upper-forearm orthopedic surgery (excluding prosthetic surgery).

You may not qualify if:

• Inpatients defined as a patient who is formally admitted (or "hospitalized") to an institution for treatment and/or care and stays for a minimum of one night in the hospital or other institution providing inpatient care;
• Patients undergoing emergency procedures.

Sponsors & Collaborators

• Algemeen Ziekenhuis Maria Middelares: lead
• University Ghent: collaborator

Study Sites (1)

AZ Maria Middelares

Ghent, 9000, Belgium

Location

Study Officials

• Ella Hermie, MSc

  Algemeen Ziekenhuis Maria Middelares

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Ella Hermie, MSc

CONTACT

0032 9 246 17 03; ella.hermie@mijnziekenhuis.be

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: studiecoordinator, PhD student

Study Record Dates

• First Submitted: December 13, 2024
• First Posted: December 19, 2024
• Study Start: December 1, 2025
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: December 19, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

BE (1)